BCAB - BioAtla Inc. (BCAB) Q4 2023 Earnings Call Transcript
2024-03-26 19:21:09 ET
BioAtla, Inc. (BCAB)
Q4 2023 Earnings Conference Call
March 26, 2024, 4:30 PM ET
Company Participants
Bruce Mackle - Investor Relations, LifeSci Advisors
Jay Short - Chairman, Chief Executive Officer and Co-Founder
Richard Waldron - Chief Financial Officer
Sheri Lydick - Chief Commercial Officer
Eric Sievers - Chief Medical Officer
Conference Call Participants
Dev Prasad - Jefferies
Kaveri Pohlman - BTIG
Arthur He - H.C. Wainwright
Reni Benjamin - Citizens JMP Securities
Presentation
Operator
Greetings and welcome to the BioAtla Fourth Quarter and Full Year 2023 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It's now my pleasure to introduce your host, Bruce Mackle, with LifeSci Advisors. Thank you, Mr. Mackle. You may begin.
Bruce Mackle
Thank you, operator, and good afternoon, everyone. With me today on the phone from BioAtla are Dr. Jay Short, Chairman, CEO and Co-Founder; and Richard Waldron, Chief Financial Officer.
Following today's call, Dr. Eric Sievers, Chief Medical Officer; and Sheri Lydick, Chief Commercial Officer, will join Jay and Rick for a short Q&A. Earlier this afternoon, BioAtla released financial results and a business update for the fourth quarter and full year ended December 31, 2023. A copy of the press release and corporate presentation are available on the company's website....
BioAtla, Inc. (BCAB) Q4 2023 Earnings Call Transcript